Mutations in TRPM1 Are a Common Cause of Complete Congenital Stationary Night Blindness  by van Genderen, Maria M. et al.
REPORT
Mutations in TRPM1 Are a Common Cause
of Complete Congenital Stationary Night Blindness
Maria M. van Genderen,1 Mieke M.C. Bijveld,1 Yvonne B. Claassen,2 Ralph J. Florijn,3
Jillian N. Pearring,7 Francoise M. Meire,8,9 Maureen A. McCall,6 Frans C.C. Riemslag,1
Ronald G. Gregg,6,7 Arthur A.B. Bergen,3,5 and Maarten Kamermans2,4,*
Congenital stationary night blindness (CSNB) is a clinically and genetically heterogeneous group of retinal disorders characterized by
nonprogressive impaired night vision and variable decreased visual acuity. We report here that six out of eight female probands with
autosomal-recessive complete CSNB (cCSNB) had mutations in TRPM1, a retinal transient receptor potential (TRP) cation channel
gene. These data suggest that TRMP1 mutations are a major cause of autosomal-recessive CSNB in individuals of European ancestry.
We localized TRPM1 in human retina to the ON bipolar cell dendrites in the outer plexifom layer. Our results suggest that in humans,
TRPM1 is the channel gated by the mGluR6 (GRM6) signaling cascade, which results in the light-evoked response of ON bipolar cells.
Finally, we showed that detailed electroretinography is an effective way to discriminate among patients withmutations in either TRPM1
or GRM6, another autosomal-recessive cCSNB disease gene. These results add to the growing importance of the diverse group of TRP
channels in human disease and also provide new insights into retinal circuitry.Congenital stationary night blindness (CSNB), caused by
defective signaling from photoreceptor to bipolar cells, is
characterized by a reduced or absent b-wave and a normal
a-wave in the electroretinogram (ERG). Two types of CSNB
can be distinguished by use of the standard ﬂash ERG: the
‘‘complete’’ form (cCSNB), also known as type 1 CSNB or
CSNB1 (MIM 310500),1 is characterized by the complete
absence of rod pathway function; and the ‘‘incomplete’’
form (icCSNB), also known as type 2 CSNB or CSNB2
(MIM 300071), is caused by impaired rod and cone
pathway function. cCSNB is caused by postsynaptic defects
in depolarizing or ON bipolar cell signaling, whereas the
hyperpolarizing or OFF bipolar cell pathway is intact.
CSNB segregates in X-linked and autosomal-recessive
form. X-linked cCSNB is caused by mutations in NYX
(MIM 300278), which encodes nyctalopin, a leucine-rich
proteoglycan of unknown function.2–4 One form of auto-
somal-recessive CSNB is caused by mutations in GRM6
(MIM 604096), which encodes the metabotropic gluta-
mate receptor 6 (mGluR6).5,6 Nyctalopin and mGluR6
are localized on the dendrites of ON bipolar cells7,8 and
are required for signal transmission from photoreceptors
to ON bipolar cells. Both are involved in modulating
a nonspeciﬁc cation channel that has been identiﬁed
through animal studies to be TrpM1.9,10 Modulation of
TrpM1 leads to a change in the membrane potential of
ON bipolar cells, thus making TrpM1 essential for ON
bipolar cell function.
If TRPM1 (MIM 603576) indeed plays a role in ON
bipolar cell signaling in humans, it should also be localized
postsynaptically on the ON bipolar cell dendrites in the730 The American Journal of Human Genetics 85, 730–736, Novemouter plexiform layer (OPL) of the retina (Figure 1A). To
examine this, we reacted transverse sections of normal
human retina with antibodies to TRPM1 and Ribeye (a
presynaptic marker) or peanut agglutinin (PNA) (a marker
for cone terminals) (Figure 1). Images of TRPM1 and PNA
staining (Figure 1B) showed dense TRPM1 puncta closely
aligned with PNA-positive cone photoreceptor terminals.
Weaker TRPM1 staining in the inner nuclear layer was
associated with bipolar cell somata. Staining for both
TRPM1 and Ribeye (Figure 1C) showed closely associated,
but nonoverlapping, labeling in large cone and small rod
terminals. This localization of TRPM1 strongly resembles
that of nyctalopin8 and indicated that it, too, is localized
on rod ON bipolar cell dendrites.
Given this expression pattern and the role of TRPM1 in
ON bipolar cell signaling in animals,9,10 we hypothesized
that individuals with autosomal-recessive cCSNB lacking
mutations in either GRM6 or NYX may have mutations
in TRPM1. We subsequently screened eight female auto-
somal-recessive CSNB probands of European ancestry for
mutations in TRPM1, after the other cCSNB genes had
been excluded. We sequenced 26 exons (accession no.
NM_002420_4) and adjacent splice sites and found
TRPM1 mutations in six probands. All six probands had
normal retinas on the basis of funduscopy (data not
shown). Their clinical characteristics, including represen-
tative dark-adaptation curves and ISCEV (International
Society for Clinical Electrophysiology of Vision) standard
ERG, are presented in Table S1, Figure S1, and Figure S2
(available online). Five probands carried either homozy-
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proband we found only a single heterozygous mutation
(Table S1). None of the described mutations were present
in 210 control chromosomes.
Proband 1 was homozygous for a 36,445 bp deletion that
includes exons 2–7 (Figure 2Ai). The deleted chromosome
was present in both parents and was absent from the
proband’s unaffected sister. This deletion removes exons
used in four additional isoforms recently described by
Oancea et al.11 and should produce a null allele for all
isoforms of TRPM1. Proband 2 (Figure 2Aii) was compound
heterozygouswith a single-bpdeletion in exon3 (c.83delA),
resulting in a frameshift (p.Asn28Metf62) on one allele. The
other allele carried a c.1600G>A transition in exon 14,
which generates a p.Gly534Arg missense mutation. The
proband’s unaffected parents were carriers (mother for
c.83delA; father for c.1600G>A), whereas the unaffected
sister had no mutations. The parents were not aware of
any possible consanguinity. Alamut analysis, which pre-
dicts mutation impact on function, classiﬁes p.Gly534Arg
as weak, although p.Gly534 is conserved in TRPM1 chan-
nels from human to frog (Figure 2B), suggesting functional
importance. Proband 3 had a c.296T>C transversion in
exon 4, which results in a p.Lys99Pro substitution on one
allele, and a c.1832C>T transversion in exon 16, which
results in p.Pro611His missense mutations (Figure 2Aiii)
on the other allele. DNA samples from the parents were
not available. However, the c.296T>Cmutation was found
in the unaffected sister of proband 3, and the c.1832C>T
mutation was found in the unaffected brother. Alamut
analysis predicts that both are likely to interfere with the
functionof theprotein, andeachcontainshighly conserved
residues. Proband 4 carries a c.220C>T transition in exon 4,
which results in a p.Arg74Cys substitution on one allele,
and a c.1091T>G transversion in exon 9, which results in
a p.Leu364Arg substitution (Figure 2Aiv) on theother allele.
Only the c.220C>T mutation was found in proband 3’s
mother, and DNA was not available for her father. Alamut
analysis predicts that both are highly conserved residues
likely to interfere with the function of the protein, and
each contains highly conserved residues (Figure 2B). We
identiﬁed two mutations (c.3061þ1G>A and c.3142G>A)
in proband 5; the c.3142G>A mutation is located in
the ion transport domain and, according to Alamut anal-
ysis, interferes with the function of the protein. The
c.3061þ1G>A mutation most likely affects the splicing
pattern of the gene (deletion of exon 22 expected). Finally,
we identiﬁed a single heterozygous splice-site mutation
(c.2250þ1G>A) in proband 6. Themutations thatwere pre-
dicted to alter splicing (probands 5 and 6) require further
functional conﬁrmation.
Scotopic (rod), photopic (cone), mixed cone-rod, and
30 Hz photopic ERG responses were measured in control
subjects (Figure S2A) and in cCSNB probands with GRM6,
NYX, and TRPM1 mutations (Figures S2B–S2D), with the
use of ISCEV standard conditions.12,13 In control subjects,
the mixed cone-rod ERG has a negative-going a-wave, due
to photoreceptor activation, preceding a positive-going
b-wave, caused by ON bipolar cell depolarization (mixed;
Figure S2A). Consistent with their diagnosis, all cCSNB
probands showed mixed ERG responses of normal a-wave
and no b-wave phenotype (mixed; Figure S2B–S2D). No
scotopic ERG response could be identiﬁed. Their photopic,
30 Hz ﬂicker ERG responses were normal, and oscillatory
potential (OP) responses were normal to subnormal. So
far, all of our probands had a phenotype similar to those
of mouse models with mutations in Grm6, TrpM1,10,14
and Nyx,15 in which the absence of ON bipolar cell activity
has been directly conﬁrmed.8
Figure 1. TRPM1 Is Localized to the OPL in the Human Retina
Human eyes, obtained from the Kentucky Lions Eye Bank, were prepared as described in Gregg et al.8 Antibodies and their dilutions were
as follows: anti-ctbp2/ribeye (BD Biosciences PharMingen, San Diego, CA, USA; 1:1000), rhodamine-labeled PNA (Vector Labs, Burlin-
game, CA, USA; 1 mg/ml), and anti-TRPM1 (Sigma, Saint Louis, MO, USA; 1:300).
(A) Transverse section through a ‘‘peri-foveal’’ area of a normal human retina. Abbreviations are as follows: ONL, outer nuclear layer;
OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer.
(B) Immunolocalization shows close apposition of TRPM1 puncta with PNA-positive cone photoreceptor terminals in the OPL.
(C) Immunolocalization shows close apposition of TRPM1 with Ribeye, a rod and cone photoreceptor synaptic ribbon marker.
Scale bar represents 25 mm in (A) and 5 mm in (B) and (C).The American Journal of Human Genetics 85, 730–736, November 13, 2009 731
Figure 2. TRPM1 Mutations Are Present in Six Probands with Autosomal-Recessive cCSNB
(Ai-Aiv) Four families in which two deleterious and/or highly conserved mutations in the TRPM1 channel were identiﬁed. Each of the
subsections, Ai–Aiv, shows the mutation, the predicted impact on the amino acid sequence, and a small portion of the chromatogram
showing the mutant sequence. (Ai) Proband 1 has a 36,455 bp deletion in TRPM1 (chromosome 15). To conﬁrm that the deletion was732 The American Journal of Human Genetics 85, 730–736, November 13, 2009
Figure 3. ERG Responses from Control
Subjects and Probands with GRM6, NYX,
and TRPM1 Mutations
The 15 Hz ﬂicker ERG responses from
representative healthy control subjects
and probands with GRM6, NYX, and
TRPM1 mutations differ (B–D, respec-
tively). ERG responses were recorded with
the use of DTL electrodes (right eye: gray;
left eye: black). Shown are scotopic 15 Hz
ﬂicker ERG responses to a series of ten
stimuli of increasing intensities starting
at 1.72 log scot td3s (top trace) up to
0.44 log scot td3s (bottom trace). Between
1.72 and 0.56 log scot td3s rod signals
in the normal retina use the primary
(rod / ON bipolar cell / AII amacrine
cell) pathway, and at mesopic levels from
0.56 log scot td3s upwards, they use
the secondary (rod/ cone/ bipolar cell)
pathway. At approximately 0.56 log scot
td3s, the signals transferred through the two rod pathways are equal in amplitude but lag one another by half a phase and interfere
destructively6,16,17 (see control subject in A: ‘‘Normal’’). In probands with NYX (C) or TRPM1 (D) mutations, ERG responses from the
primary rod pathway could not be identiﬁed, whereas responses from the secondary rod pathway were within normal limits. In the
proband with GRM6 mutations, ERG responses could be measured at all intensities, but the responses had abnormal phase behavior.In contrast to the standard ﬂash ERG, a 15Hz ﬂicker
ERG paradigm can subdivide cCSNB patients with and
without GRM6 mutations and provide insight into
dysfunction in the various rod pathways6 (Figure 3). At
low scotopic intensities, the response is dominated by
the primary rod pathway (Figure 4Ai; rod/ rod ON-BC/
AII amacrine cell, whereas the response is dominated at
high scotopic intensities by the secondary rod path-
way (Figure 4Aii; rod /cone [via gap junctions between
rod and cone pedicles] / BC).16,17 In control subjects
(Figure 3A), the ERG amplitude decreases and then reaches
a null at about 0.56 log scot td3s before increasing again
at higher intensities. This occurs because of destructive
interference, caused by out-of-phase signals from the
primary and secondary rod pathways. None of the 15 Hz
ERG responses of our TRPM1 probands showed a pattern
similar to either the control subject (Figure 3A) or our
autosomal-recessive cCSNB proband with GRM6 muta-
tions (Figure 3B). Rather, the ERG responses of all TRPM1
probands (Figure 3D) were identical to those of cCSNB
patients with NYX mutations (Figure 3C). Speciﬁcally,
responses at low intensities were completely absent,The Americawhereas they were similar to normal at higher intensities,
revealing the complete absence of the primary rod path-
way and mildly reduced activity of the secondary rod
pathway. As reported previously for autosomal-recessive
cCSNB patients with GRM6mutations, our GRM6 proband
had responses at all intensities that were markedly dissim-
ilar in phase as compared to normal responses.6 It has
been suggested that this is due to the interaction between
the secondary and tertiary rod pathways (Figure 4Aiii;
rod/ OFF-BCs).6
Distinct CSNB phenotypes also occur in retinal ganglion
cell activity in Nyx and Grm6 mutant mice.18 Nyx mutant
ganglion cells show spontaneous rhythmic bursting
activity with a fundamental frequency of about 4 Hz;
whereas the spontaneous activity of Grm6 mutant
ganglion cells is the same as that of the wild-type.19
Furthermore, the spatial organization of all Nyx mutant
ganglion cells is signiﬁcantly altered, whereas Grm6 OFF
ganglion cells have normal receptive ﬁeld center/surround
organization.18 Because the genes implicated in cCSNB are
all located in the ON bipolar cell dendrites, our data imply
that, in both humans andmice, the state of the ON bipolarpresent in family members, we performed a PCR, using forward primers 50 UTR (for the mutant allele) and TRPM1 exon 6F (for the WT
allele) in combinationwith a common reverse primer, TRPM1 exon 7R. This PCR generated the predicted 3411 bp fragment from theWT
allele and a 2293 bp fragment from the mutant allele. The ethidium-bromide-stained gel shows that both parents were carriers of this
mutation and that it is absent in the proband’s unaffected sister. (Aii) The pedigree for proband 2 showed that she inherited one mutant
TRPM1 allele from each parent (c.83delA, c.1600C>A), whereas her unaffected sister inherited twoWT TRPM1 alleles. (Aiii) The pedigree
of proband 3 also showed consistent segregation of the mutant alleles with the disease phenotype. The proband had twomutant TRPM1
alleles (c.296T>C; c.1832C>A), whereas each of her two unaffected siblings had only one. Both parents died, but it can be deduced from
the segregation pattern that each parent carried only one of the mutations found in the proband. (Aiv) Proband 4 inherited one of the
mutant TRPM1 alleles (c.220C>T) fromhermother. DNA fromher father was not available. The secondmutant allele (c.1091T>G) could
have been inherited from her father or could be a de novo mutation.
(B) Conservation of the ﬁvemissensemutations indentiﬁed in probands 2–4. In every species for which data were available, all ﬁvemuta-
tions were located in highly conserved regions. The darkness of the blue color indicates the amount of conservation, with dark blue indi-
cating the most conserved. All sequence changes were evaluated for their pathogenicity with the Alamut software. The study followed
the tenets of the Declaration of Helsinki and was approved by the ethics committee of the Academic Medical Centre, Amsterdam. All
participants provided signed informed consent for participation in the study.n Journal of Human Genetics 85, 730–736, November 13, 2009 733
cells differs between TRPM1 and NYX mutants and GRM6
mutants.
Figure 4B illustrates the currently identiﬁed proteins that
function in ON bipolar cell signaling and cause a cCSNB
phenotype in humans and/or mice. mGluR6 is the
receptor sensing glutamate release by photoreceptors,20,21
GaO and Gb5 are second messengers in this G protein
signaling cascade.22,23 TRPM1 is most likely the cation
channel that eventually modulates the light-evoked ON
bipolar cell depolarization.9,10 Nyctalopin, whose function
has not yet been conclusively established, may trafﬁc and/
or anchor TRPM1 to the membrane.24 Activation of
mGluR6 leads to the closure of TRPM1 channels. There-
fore, mutations in mGluR6 are likely to cause the TRPM1
channel to be open and conduct an inward current. In
contrast, mutations in TRPM1 are likely to eliminate
both the TRPM1 channel and the inward current. The
simplest model predicts that ON bipolar cells in our
probands with TRPM1 mutations will be hyperpolarized,
whereas those with GRM6mutations will be constitutively
depolarized. This should differentially affect the sustained
activity of AII amacrine cells, a vital component of infor-
mation ﬂow in the rod pathways. These changes could
shift the balance between the remaining secondary and
tertiary rod pathways and result in the differences that
we observe in the 15 Hz ERG ﬂicker response.
Overall, we investigated 11 autosomal-recessive cCSNB
patients from nine families. Three patients from one
family had mutations in GRM6. Six probands from six
families had TRPM1 mutations. The remaining two
patients may represent the opportunity to identify addi-
tional genes that regulate either TRPM1 channel activity
or the mGluR6 signaling cascade. That said, our results
indicate that TRPM1 mutations will account for more
than 50% of autosomal-recessive cCSNB cases in our
patient cohort of European ancestry. TRP channels are
a diverse family of about 30 members that are now known
to be expressed and participate in central and peripheral
Figure 4. Rod Signaling in the Mammalian Retina Travels via Three Routes
(Ai) The primary rod pathway (rod/ ON bipolar cell/ AII amacrine cell). Rods release glutamate onto rod ON bipolar cells, which
provide an excitatory input to AII amacrine cells, which are electrically coupled to cone ON bipolar cells and inhibit cone OFF bipolar
cells. Signaling in this pathway completely depends on the mGluR6 signaling cascade (B). This pathway is affected in cCNSB.
(Aii) The secondary rod pathway (rod/ cone/ bipolar cell). The electrical coupling between rods and cones allows the ﬂow of rod
signals into the cones and glutamate release into the cone ON and OFF bipolar cells.
(Aiii) The tertiary rod pathway (rod/OFF bipolar cell). A direct glutamatergic input from rods to cone OFF bipolar cell. Note that the
latter two pathways are in principle independent of the rod ON bipolar cell signaling pathway (Ai). Red arrows indicate sign-inverting
synapses, and green arrows indicate sign-preserving synapses. Abbreviations are as follows: BC, bipolar cell; AC, amacrine cell; GC,
ganglion cell.
(B) Schematic representation of signaling between photoreceptors and bipolar cells (marked by dashed red circle in panel Ai) and the
mGluR6 signaling cascade. Glutamate release from rods depends on the intracellular Ca2þ concentration, which is regulated by an
L-type voltage-gated Ca2þ channel (CACNA1F) in the rod synaptic terminal. Glutamate binds to metabotropic glutamate receptors
mGluR6 (GRM6) and activates an intracellular cascade involving GaO and Gb5, leading to the closure of the TRPM1 channel. NYX
also plays a role, but its function is currently unknown. GRM6, NYX, and TRPM1 have now been implicated in human cCSNB.2,6 It
is less likely that human patients with mutations in either GaO or Gb5 will be found, given that the GaO22 mutation is lethal in
mice and Gb5 has a primary photoreceptor-degeneration phenotype.23734 The American Journal of Human Genetics 85, 730–736, November 13, 2009
nervous system function. To date, mutations in these
channels have rarely been associated with diseases of the
nervous system. However, our results suggest that they
may represent an unexplored target for these diseases.
Supplemental Data
Supplemental data include two ﬁgures and two tables and can be
found with this article online at http://www.cell.com/AJHG.
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Note Added in Proof
The involvement of TrpM1 in ON bipolar cell function in
mouse retina has been conﬁrmed by Morgans et al.:
TRPM1 is required for the depolarizing light response in
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